Beyond their role in glucose regulation, SGLT-2 inhibitors have demonstrated remarkable protective effects on both the heart and kidneys [16,17], making them valuable in managing complications associated with diabetes. The gene discussed is SLC5A2; the disease is diabetes mellitus.